Zerhouni Comments
Zerhouni, in a response to a question from Harkin, said, "From my standpoint, it is clear today that American science will be better-served, and the nation will be better-served if we let our scientists have access to more stem cell lines" (Los Angeles Times, 3/20). Harkin at the hearing asked Zerhouni if scientists will have "a better chance of finding ... new cures, new interventions for diseases, if the current restrictions on embryonic stem cell research are lifted." Zerhouni responded, "I think the answer is yes," adding that the embryonic stem cell lines currently available for research "will not be sufficient for the research we need to do." He also said that NIH should lead embryonic stem cell research because the agency has more scientific expertise than any other institution worldwide and because the agency has a strong history of implementing safeguards in new research, CQ HealthBeat reports. Harkin also asked if adult stem cell research has greater potential than embryonic stem cell research. Zerhouni said that such views are an overstatement and do not "hold scientific water too well," adding that "all angles of stem cell research should be pursued" (Reichard, CQ HealthBeat, 3/19). It is "in the best interest of our scientists, our science, our country that we find ways -- that the nation finds a way to allow the science to go full speed on both adult and embryonic stem cell research," Zerhouni said (Dunham, Reuters, 3/20).
Reaction
White House spokesperson Tony Fratto said that Zerhouni is free to express his opinion on stem cell research but added that Bush will set the policy. "After careful and thoughtful deliberation with government and outside experts, there was only one moral line that the president said he would not cross -- and that is that federal taxpayer dollars should not be used in the destruction of embryos," Fratto said (Los Angeles Times, 3/20). An unnamed White House spokesperson added that Zerhouni would be breaking Bush administration policy if he called for making additional stem cell lines eligible for federal funding (CQ Healthbeat, 3/19). According to the Times, several researchers welcomed Zerhouni's comments. Renee Reijo Pera, director of the embryonic stem cell program at Stanford University, said she thinks Zerhouni's testimony "in the long run ... will make a difference" in restrictions on federal funding for the research. Wendy Wright, president of Concerned Women for America, said Zerhouni's comments showed that "he's not looking at the issue objectively," adding that he has ignored the potential of stem cells derived from sources other than embryos (Los Angeles Times, 3/20).
"Reprinted with permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Комментариев нет:
Отправить комментарий